FDA Brief

Warning letters Devices

FDA warning letter to

Shenzhen Moyeah Intelligent Life Technology Co.

High riskIssued Aug 8, 2024Posted Aug 28, 2024Center for Devices and Radiological Health

Shenzhen Moyeah sold ozone and UV CPAP cleaner and sanitizer devices in the U.S. without FDA clearance or approval, FDA says.

What happened

FDA reviewed the labeling on the firm's websites, moyeahstore.com and moyeahcpap.com, last visited June 4, 2024, and found CPAP cleaner, sanitizer and disinfector devices promoted with sterilization claims but with no FDA marketing authorization. FDA had already written to the firm's U.S. agent on May 26, 2021, saying the products appeared to be devices and were not Class I exempt, and sent follow-up emails on March 3, 2023, and April 21, 2023. The letter says the firm has not responded to that correspondence.

What FDA found

  1. The firm sold these devices in the U.S. without an approved premarket approval (PMA) application, the FDA review path for higher-risk devices.

    Section 501(f)(1)(B), 21 U.S.C. § 351(f)(1)(B); section 515(a), 21 U.S.C. § 360e(a)
  2. The firm also had no approved investigational device exemption (IDE), the permission FDA gives to study an unapproved device in people.

    Section 520(g), 21 U.S.C. § 360j(g)
  3. The firm delivered the devices into interstate commerce for commercial distribution without submitting a 510(k) premarket notification, the usual step to show a device is substantially equivalent to one already legally sold.

    Section 502(o), 21 U.S.C. § 352(o); section 510(k), 21 U.S.C. § 360(k); 21 CFR 807.81(a)
  4. Website labeling claims the products sterilize or kill 99.9% to 99.99% of bacteria, germs, mold and fungi on CPAP machines, masks and tubing, which makes them devices under the law.

    Section 201(h), 21 U.S.C. § 321(h)
  5. One product is titled "FDA Approved" on the website even though the letter says the firm has no FDA clearance or approval for it.

What FDA wants

FDA asks the firm to stop any activity that misbrands or adulterates the devices, such as selling them for these uses, and to reply in writing within 15 business days describing the corrections made, how it will prevent repeat violations, and a timetable if fixes will take longer.

Who should pay attention

  • online marketplaces and retailers that list CPAP cleaning accessories
  • durable medical equipment suppliers and sleep apnea product distributors
  • U.S. agents and importers acting for Chinese device makers
  • other makers of UV or ozone sanitizer devices for respiratory equipment

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Next Medical Products Company, LLC

    FDA warns Next Medical Products that its ultrasound gels were contaminated and made without required quality controls or clearance.

    High risk
  2. Peter Schiff Enterprises

    FDA warns Peter Schiff Enterprises over unapproved cardiac devices and serious quality system failures.

    High risk
  3. Pro-Optics, LLC

    FDA warned Pro-Optics about unapproved material and color changes to contact lens cases and quality system failures.

    Medium
  4. Tides Medical LLC

    FDA warns Tides Medical over APLICOR 3D wound device sold without approval, exemption, or required FDA notice.

    High risk